蛋白质结晶
微尺度化学
微流控
结晶
过饱和度
纳米技术
试剂
材料科学
高分子
微型反应器
乳状液
化学
化学工程
限制
胶体
渗透压
微技术
生物矿化
色谱法
蛋白质折叠
作者
Guangzhu Shang,Peiyi Zheng,Hengzhi Ni,Shan Wei,Luoquan Li,Xingyue Lei,Zerui Wu,Xun He,Zirui Wang,Zhongliang Zhu,Huichao Ou,Liqun He,Zida Li,Tengchuan Jin,Gang Zhao
出处
期刊:Small
[Wiley]
日期:2026-01-19
卷期号:22 (15): e10977-e10977
被引量:1
标识
DOI:10.1002/smll.202510977
摘要
Protein crystallization is essential for macromolecular structure determination, which in turn enables advances in drug discovery, enzyme engineering, and functional biology. However, conventional crystallization methods require large sample volumes, extensive screening, and long incubation times, while often yielding irreproducible results. Microfluidic droplets reduce reagent use and enable high-throughput screening, but their sealed environments fix solute concentrations at formation, limiting control over supersaturation and crystal growth. Here, we present the Droplet Concentration Control and Vision (DCCV) platform, which integrates programmable osmotic modulation with automated computer vision. Using semi-permeable double emulsion droplets, DCCV allows post-formation, dynamic tuning of solute concentrations through engineered osmotic gradients. A deep learning-based imaging system provides high-throughput, label-free quantification of droplet size, permeability, and morphology over time. As a demonstration, DCCV produced X-ray-quality protein crystals within 20 h, supported by a predictive model of osmotic transport. Beyond crystallization, DCCV establishes a versatile framework for microscale reaction engineering, biomolecular self-assembly, and materials discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI